<DOC>
	<DOCNO>NCT02363348</DOCNO>
	<brief_summary>Randomized double-blind control clinical trial ass efficacy safety L-arginine prevent preeclampsia . apply pregnant woman risk factor preeclampsia . main result development preeclampsia well side effect take l arginine besides perinatal outcome</brief_summary>
	<brief_title>Efficacy Safety L Arginine Prevent Preeclampsia</brief_title>
	<detailed_description>Two group form . one receive L arginine 3 gram orally day 20th week pregnancy . group receive placebo . Each three week evaluate search high blood pressure proteinuria . The follow-up end pregnancy two week</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>one risk factor develop preeclampsia ( nulliparous , previous history preeclampsia , chronic hypertension , BMI â‰¥30 ) pregnant woman carrier chronic renal failure pre gestational diabetes multiple pregnancy remove reason receive medication would interfere interpretation result ( aspirin )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>L arginine</keyword>
	<keyword>Preeclampsia</keyword>
</DOC>